Filing Flows › Newmont (NEM) › Sales from Concentrate and Other Production revenue
Newmont (NEM) Sales from Concentrate and Other Production revenue by quarter
Newmont's Sales from Concentrate and Other Production revenue was $2.2B in Q3 2026 (third quarter 2026), +21% from Q2 2026. Over the last 7 quarters it ranged from $1.8B (Q2 2026) to $2.5B (Q1 2026).
| Quarter | Sales from Concentrate and Other Production revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $2.2B | +21% | +8% |
| Q2 2026 | $1.8B | -27% | -9% |
| Q1 2026 | $2.5B | +7% | +35% |
| Q4 2025 | $2.4B | +14% | — |
| Q3 2025 | $2.1B | +2% | — |
| Q2 2025 | $2.0B | +8% | — |
| Q1 2025 | $1.9B | — | — |
Q3 2026 at a glance
Newmont, Q3 2026: revenue $6.4B (+15% year over year), operating margin 49.7%, net earnings $2.5B, operating cash flow $2.8B. The chart follows the revenue to costs, profit and cash.
Questions
What is Newmont's Sales from Concentrate and Other Production revenue?
Newmont's Sales from Concentrate and Other Production revenue was $2.2B in Q3 2026 (third quarter 2026), +21% from Q2 2026.
How has Newmont's Sales from Concentrate and Other Production revenue changed?
Over the last 7 quarters it ranged from $1.8B (Q2 2026) to $2.5B (Q1 2026).